← Evidence map

ArticleEuropean heart journal. Cardiovascular pharmacotherapy2017

Response to the 'Comment on the editorial by Turner et al. on Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.'

J Turner Rick et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Response to the 'Comment on the editorial by Turner et al. on Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.' | OpenQuestion